Trademark: 97559351
Status Date
Tuesday, April 2, 2024
Filing Date
Monday, August 22, 2022
Published for Opposition
Tuesday, August 15, 2023
5 Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; biological preparations for the treatment of cancer and tumors
42 Pharmaceutical research and development
Apr 3, 2024
Notice Of Approval Of Extension Request E-Mailed
Apr 2, 2024
Sou Extension 1 Granted
Apr 2, 2024
Sou Extension 1 Filed
Apr 2, 2024
Sou Teas Extension Received
Apr 1, 2024
Teas Change Of Correspondence Received
Apr 1, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 1, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 1, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 1, 2024
Teas Change Of Owner Address Received
Oct 10, 2023
Noa E-Mailed - Sou Required From Applicant
Aug 15, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 15, 2023
Published For Opposition
Jul 26, 2023
Notification Of Notice Of Publication E-Mailed
Jul 8, 2023
Approved For Pub - Principal Register
Jul 7, 2023
Teas/Email Correspondence Entered
Jul 6, 2023
Correspondence Received In Law Office
Jul 6, 2023
Teas Response To Office Action Received
Jun 12, 2023
Notification Of Priority Action E-Mailed
Jun 12, 2023
Priority Action E-Mailed
Jun 12, 2023
Priority Action Written
Jun 8, 2023
Assigned To Examiner
Sep 11, 2022
New Application Office Supplied Data Entered
Aug 25, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
